Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | 119,226 | 132,606 | 57.73% | +13,380 |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 800,399 | 0 | 12,998 | 24,636 | 10.72% | +11,638 |
| Maze Therapeutics, Inc.(MAZE) | 522,657 | 522,657 | 0 | 13,552 | 21,654 | 9.43% | +8,101 |
| Alector, Inc. | 0 | 3,887,200 | +3,887,200 | 0 | 6,064 | 2.64% | +6,064 |
| CYTOKINETICS INC(CYTK) | 458,295 | 458,295 | 0 | 25,188 | 29,120 | 12.68% | +3,932 |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | 5,220 | 8,460 | 3.68% | +3,240 |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | 6,424 | 7,171 | 3.12% | +747 |